Validation of a novel capillairy bloodsampling kit (Demecal) for the detection of HIV antibodies

Validation of a novel capillairy bloodsampling kit (Demecal) for the detection of HIV antibodies - Home sampling of capillairy blood for HIV antibody detection

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON31729

Enrollment

Registered

2008-05-20

Start date

2008-12-10

Completion date

Unknown

Last updated

2024-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

nvt

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Routine blood sampling requested for HIV positive patient.

Exclusion criteria

Exclusion criteria: Younger than 18 years of age No venal blood drawing possible

Design outcomes

Primary

Measure	Time frame
Measered HIV-antibody detection levels in capillairy plasma will be compared with venous blood. Tests in both blood samples should be 100% comparable.	—

Secondary

Measure	Time frame
none	—

Countries

Netherlands

Outcome results